ACCESS AND PRODUCTIVITY OUTCOMES WITH RADIOLOGY TECHNOLOGY IN WESTERN SYDNEY Outcomes despite insufficient indexation, Government funding and workforce shortages
With
Leon Berkovich, CEO
GE HealthCare Australia and New Zealand
Dr Mansoor Parker
Diagnostic & Interventional Radiologist & Founding Partner,
Quantum Radiology, Sydney
SEGMENT
Filmed in Sydney | November 2025
In Western Sydney, there is currently significant growth accompanied by a notable need for cardiovascular support due to the prevalence of related diseases. It is estimated that the population in this area will reach 6 million by 2041.
With this population growth, there is also a pressing shortage of healthcare professionals in Australia, particularly in the field of radiology, where there are not enough radiographers, sonographers, MRI technicians, and nuclear medicine technicians.
Previously, conducting complex imaging studies required the expertise of highly experienced technicians. Nonetheless, advancements in technology have enabled businesses to invest in new CT scanning technologies, from organisations such as GE HealthCare, making available the first of its kind in the Southern Hemisphere.
According to Dr. Mansoor Parker, a Diagnostic and Interventional Radiologist in Western Sydney and Founder of Quantum Radiology, the technology can produce consistent, high-quality studies that do not solely rely on the skill of the technician.
Dr. Parker spoke to Australian Health Journal about the unique nature of Western Sydney as a cultural melting pot that has historically suffered from a lack of high-quality healthcare. His motivation for establishing radiology practices in this area stemmed from his own experiences of limited access to imaging services, especially MRI and interventional procedures.
He notes that the challenges faced by the population often go beyond mere accessibility, including language barriers and the need for culturally sensitive care that respects privacy while delivering high standards of healthcare.
According to Leon Berkovich, CEO of GE HealthCare Australia & New Zealand, GE HealthCare has excelled in obtaining AI patents within the imaging sector, demonstrating significant technological adoption in Australia—a mature market where clinicians are eager to integrate the latest technology across all areas. The growth in Western Sydney continues to highlight the urgent need for cardiovascular imaging services, and demographic projections indicate robust population increases.
Source: Adapted from transcript
You Might also like
-
Role of the Chief Nursing Officer
Professor Alison McMillan PSM spoke with Australian Health Journal about the role of Chief Nursing and Midwifery Officer at the Australian Government Department of Health and Aged Care.
Alison was appointed as our Chief Nursing and Midwifery Officer in November 2019.
In June 2021 Alison was awarded a Public Service Medal for outstanding public service to driving the Government’s national health response priorities during the COVID-19 pandemic, particularly to infection prevention measures.
-
Addressing Wound Management
The cost of chronic wounds in Australia is estimated to be $3 Billion per year, impacting 420,000 Australians. Not only is this a national economic concern, but more importantly, is the suffering the person may be going through.
Australian Health Journal met with Hayley Ryan, Board Director and Chair at Wounds Australia and Director at WoundRescue to hear her work in chronic wound management, palliative wounds and pressure injury prevention to comfort those living with a wound.
-
Global MedTech company brings device reprocessing plant to Australia
Cardinal Health is global medical products manufacturer and leading provider of single-use device reprocessing services in the U.S. In Australia and New Zealand, as one of the largest suppliers of medical devices, announced on 23 May 2024 that it will be opening a single-use medical device reprocessing facility in Australia – its first reprocessing facility outside the United States.
On 18 March 2025 at the Health Innovation Living Lab at the John Hunter Hospital, a further announcement was made, on the chosen single-use medical device remanufacturing facility in Beresfield, Newcastle, set to commence operation late 2025, supported by the NSW Department of Primary Industries and Regional Development.